Key Data Protection Compliance Considerations for Pharmaceutical Companies (China) | Practical Law

Key Data Protection Compliance Considerations for Pharmaceutical Companies (China) | Practical Law

A Practice Note introducing key data protection compliance issues that companies in the life sciences industry frequently encounter, in particular regarding various types of healthcare data, including clinical trial data, PI in pharmacovigilance, human genetic resources (HGR), and PI of healthcare professionals (HCP). The Note also discusses the legal basis for PI handling in common handling scenarios.

Key Data Protection Compliance Considerations for Pharmaceutical Companies (China)

Practical Law UK Practice Note w-040-5131 (Approx. 9 pages)

Key Data Protection Compliance Considerations for Pharmaceutical Companies (China)

MaintainedChina
A Practice Note introducing key data protection compliance issues that companies in the life sciences industry frequently encounter, in particular regarding various types of healthcare data, including clinical trial data, PI in pharmacovigilance, human genetic resources (HGR), and PI of healthcare professionals (HCP). The Note also discusses the legal basis for PI handling in common handling scenarios.